Registry Maastro Applicator
ConditionRectal Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMaastricht Radiation Oncology
This registry will collect data from all patients treated with the MAASTRO HDR applicator. The goal is to deepen knowledge about dose-response relationships in rectal cancer boosting, which is essential for improving future treatment approaches and patient selection.
Age ≥ 18 years.
Histological proof of rectal cancer, or a strong suspicion after imaging.
Treatment with MAASTRO HDR rectal applicator
Informed consent for longitudinal observational data collection.
Mentally incompetent patients.